November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell…
October 31, 2025 16:05 ET | Source: Clover Health Investments, Corp. WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover…
MILAN, Oct. 31, 2025 /PRNewswire/ -- Ultima Markets celebrated its Regional Partnership for the Asian territory with FC Internazionale Milano…
DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority for public voting to choose Wonders, today formally…
RIYADH, Saudi Arabia, Oct. 30, 2025 /PRNewswire/ -- In an analytical article published in Asharq Al-Awsat titled "How is Saudi…
InSolare, the 16-year-old clean energy leader extends its legacy of innovation with India's latest grid-scale storage milestone. MUMBAI, India, Oct.…
Company Reaffirms Commitment to Protect Shareholder Value and Pursue Strategic, Long-Term Capital Partners DALLAS, Oct. 30, 2025 /PRNewswire/ -- Solidion Technology…
HYDERABAD, India, Oct. 30, 2025 /PRNewswire/ -- Goyaz, India's fastest-growing occasion-led gold-plated silver jewelry brand, today announced the successful closure of…
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…